Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study
Eileen L. Yoon, Sang Bong Ahn, Dae Won Jun, Yong Kyun Cho, Do Seon Song, Jae Yoon Jeong, Hee Yeon Kim, Young Kul Jung, Myeong Jun Song, Sung Eun Kim, Hyoung Su Kim, Soung Won Jeong, Sang Gyune Kim, Tae Hee Lee
Korean J Intern Med. 2022;37(4):757-767. Published online 2022 May 6 DOI: https://doi.org/10.3904/kjim.2021.338
Citations to this article as recorded by 
ACG Clinical Guideline: Hepatic Encephalopathy
Jasmohan S. Bajaj, Sofia S. Jakab, Arun B. Jesudian, Robert S. Rahimi, Andres Duarte-Rojo, Po-Hung Chen, Robert J. Wong, Elliot B. Tapper, Puneeta Tandon
American Journal of Gastroenterology.2026; 121(3): 588. CrossRef
Covert hepatic encephalopathy in cirrhosis: implications for early diagnosis and appropriate management
Chisato Saeki, Takahiko Toyonaga, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Clinical Journal of Gastroenterology.2026; 19(3): 467. CrossRef
Differentiation of minimal and grade 1 hepatic encephalopathy using neurophysiological, neuropsychological, magnetic resonance spectroscopic, and systemic inflammatory parameters
Lalit C Kummetha, Shrey Bhatt, Venkatesh Vaithiyam, Barjesh C Sharma, Siddharth Srivastava, Bhawna Mahajan, Kalpana Bansal, Neera Chaudhry, Monica S Tandon, Sanjeev Sachdeva, Ajay Kumar, Ashok Dalal, Ujjwal Sonika
World Journal of Hepatology.2026;[Epub] CrossRef
Impact of L-carnitine supplementation on post-transplant outcomes in liver transplant candidates with sarcopenia: A randomized controlled open-label trial
Marwa Abd El-Razek Salama, Elham Ahmed Hassan, Nahed A. Makhlouf
Clinical Nutrition ESPEN.2025; 70: 50. CrossRef
Metabolites involvement in the growth and spread of liver cancer
Anurag Kumar Gautam, Vipin Kumar, Archana Bharti Sonkar, Amita Singh, Deepankar Yadav, Nitin Rajan, Pranesh Kumar, Sanjay Singh, Sudipta Saha, Vijayakumar Mahalingam Rajamanickam
Liver Research.2025; 9(4): 286. CrossRef
Factors Affecting and Promoting Health-related Quality of Life in Patients With Liver Cirrhosis: An Underestimated Domain in Patient Care
Siddheesh Rajpurohit, Balaji Musunuri, Pooja B. Mohan, Ganesh Bhat, Shiran Shetty
Journal of Clinical and Experimental Hepatology.2024; 14(1): 101264. CrossRef
Clinical Outcome Assessments in Encephalitis
Juliette Brenner, Sammy H.C. Olijslagers, Yvette S. Crijnen, Juna M. de Vries, Melissa R. Mandarakas, Maarten J. Titulaer
Neurology Neuroimmunology & Neuroinflammation.2024;[Epub] CrossRef
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, Xiangjun Chen, Shaokang Wang
Nutrients.2024; 16(8): 1232. CrossRef
The social and psychological impact of hepatic encephalopathy
Michael Sørensen, Mette Munk Lauridsen, Sara Montagnese
Metabolic Brain Disease.2024; 39(6): 1227. CrossRef
Effects of l‐carnitine on frailty status in patients with liver cirrhosis: A randomized‐controlled trial
Nasrin Motazedian, Anita Ashari, Niloofar Dehdari Ebrahimi, Mehrab Sayadi, Sarina Pourjafar, Nazanin Motazedian, Vahid Khademi, Alireza Shamsaeefar, Ahad Eshraghian
Health Science Reports.2024;[Epub] CrossRef